PBMs play a significant role in the pharmacy ecosystem. Understanding their impact is crucial for independent pharmacy owners seeking to protect their business.
Popular Categories
Previous article![Leaders in Specialty Pharmacy Share How Transformation is Accelerating]( "Leaders in Specialty Pharmacy Share How Transformation is Accelerating")
Next article![Leaders in Specialty Pharmacy Share How Transformation is Accelerating]( "Effective Marketing Strategies for Independent Pharmacies")
Effective Marketing Strategies for Independent Pharmacies
Marketing is essential for patient growth. By leveraging digital...
Leaders in Specialty Pharmacy Share How Transformation is Accelerating
This article highlights key insights from industry leaders at the 2026 Asembia meeting, emphasizing the rapid transformation of specialty pharmacy. It explores how advancements in AI, interoperability, and digital navigation are reshaping patient care and operational strategies. Independent pharmacy owners will gain valuable perspectives on adapting to these changes to maintain high-touch care while leveraging high-tech capabilities.
From Compliance to Capability: Rethinking Continuing Education in Pharmacy
This article challenges independent pharmacy owners and staff to rethink continuing education (CE) from a simple compliance checkbox to a strategic investment in professional capability. It highlights how targeted CE can empower both pharmacists and technicians to confidently expand clinical services and improve patient care. Ultimately, the piece argues that relevant, team-based education is essential for pharmacies aiming to stay competitive and meet evolving healthcare demands.
The Evolution of the Pharmacy Switch in 2026
The role of the pharmacy switch has evolved significantly, shifting from a simple neutral data router to an active participant that influences claims through AI pre-edits, copay modifications, and manufacturer eVouchers. Independent pharmacies must understand switch ownership, data flow, and hidden costs to protect their margins and effectively manage claim outcomes in 2026.
DT Vaccine: Clinical Overview and Strategic Opportunity for Community Pharmacies
The DT (Diphtheria and Tetanus) vaccine is an important alternative for children who cannot receive the pertussis component, representing a key clinical service opportunity for independent pharmacies. By collaborating with pediatric physicians and community partners, pharmacies can offer this essential immunization while generating meaningful revenue.
Effective Marketing Strategies for Independent Pharmacies
Marketing is essential for patient growth. By leveraging digital...
5 Benefits of Telepharmacy for Independent Pharmacies
Telepharmacy is bridging the gap in healthcare access. For...
AI for Independent Pharmacies: Boosting Operations & Patient Care in 2026
In the rapidly evolving landscape of 2026, artificial intelligence...
Made to Order: How Personalization Became Pharmacy’s Best Business Model
The Full Circle
The first pharmacies were compounding labs. Pharmacists...
Second Chances, Preventive Care and the Pharmacist’s Role in What Comes Next
A Conversation With Mel Chancey
By Dispense Times
Pharmacists understand pressure...
FDA Crackdown Ends the Shortage Loophole: What the New GLP-1 Compounding Rules Mean for Pharmacies
The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding pharmacies and telehealth platforms face a new era of enforcement, audits, and market consolidation.
DT Vaccine: Clinical Overview and Strategic Opportunity for Community Pharmacies
The DT (Diphtheria and Tetanus) vaccine is an important alternative for children who cannot receive the pertussis component, representing a key clinical service opportunity for independent pharmacies. By collaborating with pediatric physicians and community partners, pharmacies can offer this essential immunization while generating meaningful revenue.
5 Benefits of Telepharmacy for Independent Pharmacies
Telepharmacy is bridging the gap in healthcare access. For...
Expanding Clinical Services: A Guide for Independent Pharmacies
Expanding clinical services is no longer optional for independent...
Diabetes Management in the Modern Pharmacy: A Clinical Guide
Diabetes management is a cornerstone of clinical pharmacy. In...
FDA Crackdown Ends the Shortage Loophole: What the New GLP-1 Compounding Rules Mean for Pharmacies
The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding pharmacies and telehealth platforms face a new era of enforcement, audits, and market consolidation.
The FDA’s Crackdown on Telemedicine: Key Violations in Compounded Weight Loss Drug Marketing
The FDA is cracking down on telemedicine companies and online retailers for illegally marketing compounded weight loss drugs like semaglutide. This article details key violations, including false claims of FDA approval and misleading use of "generic" terminology, helping independent pharmacies understand the regulatory risks. Pharmacy owners can use this information to ensure their compounding and marketing practices remain strictly compliant with FDA guidelines.
The FairRx Act: How Tennessee is Exposing the PBM Playbook
Tennessee's FairRx Act is exposing CVS Health's aggressive tactics to maintain its PBM dominance, including dark-money ads and unauthorized patient texts. The legislation aims to prevent PBMs from owning the pharmacies they reimburse, creating a potential model for nationwide reform. Independent pharmacies can learn from this powerful coalition of lawmakers, regulators, and pharmacists fighting back against vertically integrated healthcare empires.
Dispense Times is your trusted resource for independent pharmacy news, business strategies, clinical insights, and industry trends. We deliver the latest updates and practical guidance straight from the community pharmacy world.
Newsletter
Don’t miss what’s changing pharmacy. Subscribe for the key updates!